BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12693402)

  • 1. Arterial stents as a therapeutic platform.
    Roitberg B
    Surg Neurol; 2003 Mar; 59(3):146-7. PubMed ID: 12693402
    [No Abstract]   [Full Text] [Related]  

  • 2. Programmable elution profile coating for drug eluting stents.
    Al-Lamee K
    Med Device Technol; 2005 Mar; 16(2):12-5. PubMed ID: 15828493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New treatment for clogged coronary arteries.
    Mayo Clin Health Lett; 2002 Dec; 20(12):4. PubMed ID: 12526107
    [No Abstract]   [Full Text] [Related]  

  • 4. General patterns and asymptotic dose in the design of coated stents.
    Bourgeois E; Delfour MC
    Comput Methods Biomech Biomed Engin; 2008 Aug; 11(4):323-34. PubMed ID: 18568828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local perivascular delivery of anti-restenotic agents from a drug-eluting poly(epsilon-caprolactone) stent cuff.
    Pires NM; van der Hoeven BL; de Vries MR; Havekes LM; van Vlijmen BJ; Hennink WE; Quax PH; Jukema JW
    Biomaterials; 2005 Sep; 26(26):5386-94. PubMed ID: 15814137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Position paper on the use of drug eluting stents in coronary heart disease].
    Mudra H; Bode C; Grube E; de Haan F; Levenson B; Schuler G; Silber S; ;
    Z Kardiol; 2004 May; 93(5):416-22. PubMed ID: 15160279
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical experience of sirolimus-eluting stents in patients with coronary artery disease at Bangkok Heart Institute.
    Lolekha P; Bhuripanyo K; Kukreja R; Mahanonda N; Numee M
    J Med Assoc Thai; 2003 May; 86 Suppl 1():S76-82. PubMed ID: 12866772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-digit target vessel revascularization in multivessel coronary interventions with sirolimus-eluting stents: goodbye to coronary bypass grafting.
    Colombo A
    Catheter Cardiovasc Interv; 2004 Sep; 63(1):61-2. PubMed ID: 15343569
    [No Abstract]   [Full Text] [Related]  

  • 9. Sirolimus-eluting stents for the treatment of atherosclerotic ostial lesions.
    Aziz S; Ramsdale DR
    J Invasive Cardiol; 2005 Jan; 17(1):13. PubMed ID: 15640532
    [No Abstract]   [Full Text] [Related]  

  • 10. Late stent thrombosis: problem or not?
    Somberg J; Weinberger J
    Am J Cardiol; 2007 Apr; 99(7):1020-3. PubMed ID: 17398205
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug-eluting stents, restenosis and revascularization.
    Ramcharitar S; Gaster AL; Daemen J; Serruys P
    Herz; 2007 Jun; 32(4):287-95. PubMed ID: 17607535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ARTS I -- the rapamycin eluting stent; ARTS II -- the rosy prophecy.
    Serruys PW
    Eur Heart J; 2002 May; 23(10):757-9. PubMed ID: 12009710
    [No Abstract]   [Full Text] [Related]  

  • 13. Overstretching undersized drug-eluting stents: a temporary solution.
    Bass TA
    Catheter Cardiovasc Interv; 2004 Apr; 61(4):461-2. PubMed ID: 15065138
    [No Abstract]   [Full Text] [Related]  

  • 14. Degradable, drug-eluting stents: a new frontier for the treatment of coronary artery disease.
    Kohn J; Zeltinger J
    Expert Rev Med Devices; 2005 Nov; 2(6):667-71. PubMed ID: 16293093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beauty's only skin deep: surface technologies emerge in stenting.
    Schwartz RS
    Catheter Cardiovasc Interv; 2003 Nov; 60(3):408-9. PubMed ID: 14571495
    [No Abstract]   [Full Text] [Related]  

  • 16. Sirolimus-eluting stent implantation in a heart transplant recipient.
    Tomai F; Gagliardi G; Proietti I
    Ital Heart J; 2004 May; 5(5):408-9. PubMed ID: 15185909
    [No Abstract]   [Full Text] [Related]  

  • 17. Vascular pathology of drug-eluting stents.
    Nakazawa G; Finn AV; Virmani R
    Herz; 2007 Jun; 32(4):274-80. PubMed ID: 17607533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of sirolimus-eluting stent implantation for the treatment of coronary artery disease in octogenarians.
    Vijayakumar M; Lemos PA; Hoye A; Ong AT; Aoki J; Granillo GR; McFadden EP; Sianos G; Hofma SH; Smits PC; van der Giessen WJ; de Feyter P; van Domburg RT; Cummins PA; Serruys PW
    Am J Cardiol; 2004 Oct; 94(7):909-13. PubMed ID: 15464675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirolimus-eluting stents versus the superficial femoral artery: second round.
    Oliva VL; Soulez G
    J Vasc Interv Radiol; 2005 Mar; 16(3):313-5. PubMed ID: 15758126
    [No Abstract]   [Full Text] [Related]  

  • 20. SCAI statement on drug-eluting stents: practice and health care delivery implications.
    Hodgson JM; King SB; Feldman T; Cowley MJ; Klein LW; Babb JD;
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):397-9. PubMed ID: 12594710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.